Work

SL-401 Mediates Potent Cytotoxicity Against CD123+ AML and MDS with Excess Blasts and Demonstrates Therapeutic Benefit in PDX Model

Year: 2016

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood.v128.22.580.580

Authors: Rajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, Rahul Ramaswamy, Ronni Wasmuth, Minh Tran, Xiaokui Mo, Amber Gordon, Donna Bucci, David Lucas, Christopher L. Brooks, Alison R. Walker, William Blum, John C. Byrd, Gerard Lozanski, Sumithra Vasu, Natarajan Muthusamy

Institutions: The Ohio State University, The Ohio State University Wexner Medical Center, Stemline Therapeutics (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2560013383

Cites:

Cited by: 1

Related to: 10